DUBLIN, Ohio, Jan. 30 /PRNewswire-FirstCall/ -- Cardinal Health Chief
Executive Officer of Clinical & Medical Products, David Schlotterbeck, will
address investors at the Merrill Lynch Global Pharmaceutical, Biotechnology
and Medical Device Conference in New York on Feb. 7 at 9:20 a.m. Eastern
Standard Time.
Mr. Schlotterbeck will discuss Cardinal Health's diverse products and
services, company performance and strategies for continued growth. His
remarks will be webcast live. To access the webcast, go to the Investors
page at http://www.cardinalhealth.com. A transcript will also be available at
http://www.cardinalhealth.com .
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an
$87 billion, global company serving the health care industry with products
and services that help hospitals, physician offices and pharmacies reduce
costs, improve safety, productivity and profitability, and deliver better
care to patients. With a focus on making supply chains more efficient,
reducing hospital-acquired infections and breaking the cycle of harmful
medication errors, Cardinal Health develops market leading technologies,
including Alaris(R) IV pumps, Pyxis(R) automated dispensing systems,
MedMined(TM) infection surveillance services and the CareFusion(TM) patient
identification system. The company also manufactures medical and surgical
products and is one of the largest distributors of pharmaceuticals and
medical supplies worldwide. Ranked No. 19 on the Fortune 500 and No. 1 in
its sector on Fortune's ranking of Most Admired firms, Cardinal Health
employs more than 40,000 people on five continents. More information about
the company may be found at http://www.cardinalhealth.com.
SOURCE Cardinal Health, Inc.
 back to top
Related links:
http://www.cardinalhealth.com
CONTACT:
Media, Jim Mazzola, +1-614-757-3690,
jim.mazzola@cardinalhealth.com, or Investors, Bob Reflogal,
+1-614-757-7542, bob.reflogal@cardinalhealth.com, both of
Cardinal Health, Inc.
|
